Thalita G. Alves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thalita G. Alves has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Cléber P. Camacho
Center of Thyroid Diseases and Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo/UNIFESP, São Paulo, Brazil
2 shared publications- Jose Gilberto Henriques Vieira
Universidade Federal de Sao Paulo, Brasil
2 shared publications - Magnus Regios Dias da Silva
Endocrinology Division, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
2 shared publications Teresa S. Kasamatsu
Laboratório de Endocrinologia Molecular e Translacional, Divisão de Endocrinologia, Departamento de Medicina, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brasil
2 shared publicationsAline Mendes
Molecular Biology Division (T.G.A., M.C.Z.M., A.M., J.R.M.M.), Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, 04044-020 São Paulo, SP, Brazil
1 shared publication- Ana Pestana
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal
1 shared publication
Latest Publications
- Open Access
Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma
Papillary thyroid carcinoma (PTC) usually presents an excellent prognosis, but some patients present with aggressive metastatic disease. BRAF, RAS, and TERT promoter (TERTp) genes are altered in PTC, and their impact on patient outcomes remains controversial. We aimed to determine the role of genetic alterations in PTC patient outcomes (recurrent/persistent disease, structural disease, and disease-specific mortality (DSM)). The series included 241 PTC patients submitted to surgery, between 2002–2015, in a single hospital. DNA was extracted from tissue samples of 287 lesions (primary tumors and metastases). Molecular alterations were detected by Sanger sequencing. Primary tumors presented 143 BRAF, 16 TERTp, and 13 RAS mutations. Isolated TERTpmut showed increased risk of structural disease (HR = 7.0, p < 0.001) and DSM (HR = 10.1, p = 0.001). Combined genotypes, BRAFwt/TERTpmut (HR = 6.8, p = 0.003), BRAFmut/TERTpmut (HR = 3.2, p = 0.056) and BRAFmut/TERTpwt (HR = 2.2, p = 0.023) showed increased risk of recurrent/persistent disease. Patients with tumors BRAFwt/TERTpmut (HR = 24.2, p < 0.001) and BRAFmut/TERTpmut (HR = 11.5, p = 0.002) showed increased risk of structural disease. DSM was significantly increased in patients with TERTpmut regardless of BRAF status (BRAFmut/TERTpmut, log-rank p < 0.001; BRAFwt/TERTpmut, log-rank p < 0.001). Our results indicate that molecular markers may have a role in predicting PTC patients’ outcome. BRAFmut/TERTpwt tumors were prone to associate with local aggressiveness (recurrent/persistent disease), whereas TERTpmut tumors were predisposed to recurrent structural disease and DSM.
Open AccessGenetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma
Papillary thyroid carcinoma (PTC) usually presents an excellent prognosis, but some patients present with aggressive metastatic disease. BRAF, RAS, and TERT promoter (TERTp) genes are altered in PTC, and their impact on patient outcomes remains controversial. We aimed to determine the role of genetic alterations in PTC patient outcomes (recurrent/persistent disease, structural disease, and disease-specific mortality (DSM)). The series included 241 PTC patients submitted to surgery, between 2002–2015, in a single hospital. DNA was extracted from tissue samples of 287 lesions (primary tumors and metastases). Molecular alterations were detected by Sanger sequencing. Primary tumors presented 143 BRAF, 16 TERTp, and 13 RAS mutations. Isolated TERTpmut showed increased risk of structural disease (HR = 7.0, p < 0.001) and DSM (HR = 10.1, p = 0.001). Combined genotypes, BRAFwt/TERTpmut (HR = 6.8, p = 0.003), BRAFmut/TERTpmut (HR = 3.2, p = 0.056) and BRAFmut/TERTpwt (HR = 2.2, p = 0.023) showed increased risk of recurrent/persistent disease. Patients with tumors BRAFwt/TERTpmut (HR = 24.2, p < 0.001) and BRAFmut/TERTpmut (HR = 11.5, p = 0.002) showed increased risk of structural disease. DSM was significantly increased in patients with TERTpmut regardless of BRAF status (BRAFmut/TERTpmut, log-rank p < 0.001; BRAFwt/TERTpmut, log-rank p < 0.001). Our results indicate that molecular markers may have a role in predicting PTC patients’ outcome. BRAFmut/TERTpwt tumors were prone to associate with local aggressiveness (recurrent/persistent disease), whereas TERTpmut tumors were predisposed to recurrent structural disease and DSM.
- 1 March 2019
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 3 (5) , 903-908
Elevated TSH in a Thyroidectomized Patient: Differential Diagnosis Beyond Noncompliance with Treatment
- 1 March 2019
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 3 (5) , 903-908
Elevated TSH in a Thyroidectomized Patient: Differential Diagnosis Beyond Noncompliance with Treatment
- Open Access
- 20 June 2018
- Published by Instituto Federal de Educacao, Ciencia e Tecnologia do Rio Grande do Norte (IFRN) in Revista Brasileira da Educação Profissional e Tecnológica
- Vol. 1 (14) , e7025
Impacto da iniciativa extensionista na comunidade local e na formação do estudante do curso técnico em massoterapia: projeto “Mãos Itinerantes – Massoterapia em eventos”
Cada vez mais nota-se a vinculação de projetos de extensão para além de uma prática profissional. A extensão pode agregar propostas mais complexas como alinhar-se à filosofia do curso, atingir número expressivo da comunidade a que pertence sem deixar de lado o incentivo à pesquisa. Assim, a indissociabilidade entre ensino, pesquisa e extensão mostra-se viável e reforça o compromisso de um aprendizado qualificado. Além disso, o impacto na comunidade local sinaliza a importância dessa iniciativa nas instituições, principalmente no que diz respeito às escolas técnicas uma vez que valoriza a capacitação profissional sem desvincular o aluno do cenário em que vive sua comunidade. O artigo propõe uma reflexão sobre esse contexto de envolvimento do projeto de extensão alinhado às demais valências de uma escola técnica trazendo os dados de um projeto na área da saúde e ligado a uma escola de formação profissional técnica. Os números expressivos ligados ao seu impacto na comunidade bem como o contato direto com sua comunidade fortalece os espaços de aprendizagem e reforça a ideia de que é possível conciliar os instrumentos de aprendizado ligados ao ensino, pesquisa e extensão. Assim, o projeto “mãos itinerantes”, premiado como melhor prática extensionista num universo de mais de 23 instituições técnicas do estado do Paraná em 2016, será aqui apresentado e também oferecido como objeto de reflexão para a importância da extensão no fortalecimento educacional e na transformação de uma realidade local.
- 20 June 2018
- Published by Instituto Federal de Educacao, Ciencia e Tecnologia do Rio Grande do Norte (IFRN) in Revista Brasileira da Educação Profissional e Tecnológica
- Vol. 1 (14) , e7025
Open AccessImpacto da iniciativa extensionista na comunidade local e na formação do estudante do curso técnico em massoterapia: projeto “Mãos Itinerantes – Massoterapia em eventos”
Cada vez mais nota-se a vinculação de projetos de extensão para além de uma prática profissional. A extensão pode agregar propostas mais complexas como alinhar-se à filosofia do curso, atingir número expressivo da comunidade a que pertence sem deixar de lado o incentivo à pesquisa. Assim, a indissociabilidade entre ensino, pesquisa e extensão mostra-se viável e reforça o compromisso de um aprendizado qualificado. Além disso, o impacto na comunidade local sinaliza a importância dessa iniciativa nas instituições, principalmente no que diz respeito às escolas técnicas uma vez que valoriza a capacitação profissional sem desvincular o aluno do cenário em que vive sua comunidade. O artigo propõe uma reflexão sobre esse contexto de envolvimento do projeto de extensão alinhado às demais valências de uma escola técnica trazendo os dados de um projeto na área da saúde e ligado a uma escola de formação profissional técnica. Os números expressivos ligados ao seu impacto na comunidade bem como o contato direto com sua comunidade fortalece os espaços de aprendizagem e reforça a ideia de que é possível conciliar os instrumentos de aprendizado ligados ao ensino, pesquisa e extensão. Assim, o projeto “mãos itinerantes”, premiado como melhor prática extensionista num universo de mais de 23 instituições técnicas do estado do Paraná em 2016, será aqui apresentado e também oferecido como objeto de reflexão para a importância da extensão no fortalecimento educacional e na transformação de uma realidade local.
- Open Access
- 18 September 2017
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 61 (5) , 460-463
Novel immunoassay for TSH measurement in rats
Measuring thyroid hormones is an important aspect for the study of metabolism and for monitoring diseases in both human and animal models. The traditional method for hormone measurement in rats is the radioimmunoassay (RIA). However, the RIA is associated with some practical disadvantages, including the use of radioactive material, the need for specialized equipment and expert staff, the short shelf-life of kits according to the half-life of the radioisotope and high costs. The objective of this study was to develop a new cost-effective method for measuring TSH levels in rats that avoids the use of radioactive material. We developed an in-house competitive immunoassay using a reference standard, polyclonal antibody produced in rabbits and biotinylated antigen. This method was tested in 64 Wistar rats that were divided into a control group (n = 41) and a group with hypothyroidism (n = 23). Our assay demonstrated an analytical sensitivity of 0.24 ng/mL (n = 12) and an intra-assay coefficient of variation (CV) of 8.9% for sera with TSH levels of 1.5 ng/mL and 13.2% for sera with TSH levels of 17.5 ng/mL (n = 14). The inter-assay CV was 13.5% for sera with TSH levels of 1.4 ng/mL and 14.5% for TSH levels of 18.2 ng/mL (n = 5). The analysis of mean TSH levels in control rats (5.06 ± 0.5701) and hypothyroid rats (51.09 ± 5.136) revealed a statistically significant difference (p < 0.001) between the groups. This method showed good sensitivity, can be automated and is low-cost compared with RIA. Our method offers a viable alternative for TSH measurement in rats.
- 18 September 2017
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 61 (5) , 460-463
Open AccessNovel immunoassay for TSH measurement in rats
Measuring thyroid hormones is an important aspect for the study of metabolism and for monitoring diseases in both human and animal models. The traditional method for hormone measurement in rats is the radioimmunoassay (RIA). However, the RIA is associated with some practical disadvantages, including the use of radioactive material, the need for specialized equipment and expert staff, the short shelf-life of kits according to the half-life of the radioisotope and high costs. The objective of this study was to develop a new cost-effective method for measuring TSH levels in rats that avoids the use of radioactive material. We developed an in-house competitive immunoassay using a reference standard, polyclonal antibody produced in rabbits and biotinylated antigen. This method was tested in 64 Wistar rats that were divided into a control group (n = 41) and a group with hypothyroidism (n = 23). Our assay demonstrated an analytical sensitivity of 0.24 ng/mL (n = 12) and an intra-assay coefficient of variation (CV) of 8.9% for sera with TSH levels of 1.5 ng/mL and 13.2% for sera with TSH levels of 17.5 ng/mL (n = 14). The inter-assay CV was 13.5% for sera with TSH levels of 1.4 ng/mL and 14.5% for TSH levels of 18.2 ng/mL (n = 5). The analysis of mean TSH levels in control rats (5.06 ± 0.5701) and hypothyroid rats (51.09 ± 5.136) revealed a statistically significant difference (p < 0.001) between the groups. This method showed good sensitivity, can be automated and is low-cost compared with RIA. Our method offers a viable alternative for TSH measurement in rats.
- 1 February 2016
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 101 (2) , 653-658
Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay
Context: Calcitonin (CT) is a sensitive marker of medullary thyroid carcinoma (MTC) and is used for primary diagnosis and follow-up after thyroidectomy. However, persistently elevated CT is observed even after complete surgical removal without evidence of a recurrent or persistent tumor. Objective: To investigate the presence of assay interference in the serum CT of MTC patients who are apparently without a structural disease. Patients and Methods: We studied three index MTC cases for CT assay interference and 14 patients with metastatic MTC. The CT level was measured using an immunofluorometric assay. Screening for assay interference was performed by determination of CT levels before and after serum treatment with polyethylene glycol. Additionally, samples were analyzed by chromatography on ultra-performance liquid chromatography and protein A-Sepharose. Results: Patients with biochemical and structural disease showed CT mean recovery of 84.1% after polyethylene glycol treatment, whereas patients suspected of interference showed recovery from 2–7%. The elution profile on UPLC showed that the immunometric CT from these three patients behaved like a high molecular mass aggregate (>300 kDa). Additionally, when these samples were applied to the protein A-Sepharose, CT immunoreactivity was retained on the column and was only released after lowering the pH. Conclusions: For the first time, our results show the presence of a novel pitfall in the CT immunoassay: “macrocalcitonin.” Its etiology, frequency, and meaning remain to be defined, but its recognition is of interest and can help clinicians avoid unnecessary diagnostic investigations and treatment during the follow-up of MTC.
- 1 February 2016
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 101 (2) , 653-658
Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay
Context: Calcitonin (CT) is a sensitive marker of medullary thyroid carcinoma (MTC) and is used for primary diagnosis and follow-up after thyroidectomy. However, persistently elevated CT is observed even after complete surgical removal without evidence of a recurrent or persistent tumor. Objective: To investigate the presence of assay interference in the serum CT of MTC patients who are apparently without a structural disease. Patients and Methods: We studied three index MTC cases for CT assay interference and 14 patients with metastatic MTC. The CT level was measured using an immunofluorometric assay. Screening for assay interference was performed by determination of CT levels before and after serum treatment with polyethylene glycol. Additionally, samples were analyzed by chromatography on ultra-performance liquid chromatography and protein A-Sepharose. Results: Patients with biochemical and structural disease showed CT mean recovery of 84.1% after polyethylene glycol treatment, whereas patients suspected of interference showed recovery from 2–7%. The elution profile on UPLC showed that the immunometric CT from these three patients behaved like a high molecular mass aggregate (>300 kDa). Additionally, when these samples were applied to the protein A-Sepharose, CT immunoreactivity was retained on the column and was only released after lowering the pH. Conclusions: For the first time, our results show the presence of a novel pitfall in the CT immunoassay: “macrocalcitonin.” Its etiology, frequency, and meaning remain to be defined, but its recognition is of interest and can help clinicians avoid unnecessary diagnostic investigations and treatment during the follow-up of MTC.